Skip to main content
Rozalina McCoy, MD, Endocrinology, Baltimore, MD

Rozalina G McCoy MD MS (She/Her)

Diabetes, Lipid Metabolism


Associate Professor of Medicine

Join to view full profile
  • 670 W Baltimore StBaltimore, MD 21201

  • Phone+1 410-706-7167

Dr. McCoy is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2009

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2023 - 2027
  • MN State Medical License
    MN State Medical License 2010 - 2023
  • WI State Medical License
    WI State Medical License 2020 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2017
  • CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014-2017
  • CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Excessive HbA1c Testing among Patients with Controlled Non-insulin-requiring Type 2 Diabetes 
    Rochester, MN - 6/14/2014

Press Mentions

  • New Clinical Tool Helps Predict Short-Term Risk of Diabetes Complications Using Routine Health Data
    New Clinical Tool Helps Predict Short-Term Risk of Diabetes Complications Using Routine Health DataAugust 25th, 2026
  • The American Diabetes Association Releases “Standards of Care in Diabetes—2026”
    The American Diabetes Association Releases “Standards of Care in Diabetes—2026”December 8th, 2025
  • Among T2D Drugs, GLP-1s Top Others for Reducing CV Events
    Among T2D Drugs, GLP-1s Top Others for Reducing CV EventsOctober 22nd, 2025

Grant Support

  • "Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes in Medicare."YALE UNIVERSITY2025–2028
  • Comparative Effectiveness and Safety of Metabolic/Bariatric Surgery, GLP-1, and SGLT-2 Medications for Patients with Obesity and Type 2 DiabetesKAISER FOUNDATION RESEARCH INSTITUTE2024–2028
  • Center for Seniors Uniting Nationwide to Support Health, INtegrated care, and Economics (SUNSHINE)UNIV OF MARYLAND, COLLEGE PARK2025–2027
  • Comparative Effectiveness and Safety of Osteoporosis Drug TherapiesMAYO CLINIC ROCHESTER2022–2027

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: